Bacterial Synthesis of Nanoparticles: Mechanisms and Biomedical Applications
Main Article Content
Abstract
Numerous scientific disciplines have experienced revolutionary changes due to the rapid emergence of nanotechnology, specifically in biotechnology and medicine. The involvement of harmful chemicals and energy-consuming physical methods of nanoparticle manufacturing results in severe toxicological concerns with respect to the environment, ecology, and medicine. Consequently, biological methodologies have become highly efficient, biocompatible, and sustainable alternatives. Through strictly controlled biochemical mechanisms in intracellular and extracellular processes, prokaryotes, more precisely bacteria, have proven to be highly efficient for green, scalable manufacturing of metallic, bimetallic, and metal oxide nanoparticles. These natural processes are facilitated through specialized microbial enzymes, structural proteins, extracellular polymeric substances (EPS), and intracellular metabolic pathways. Natural capping provides high colloidal stability, reduced agglomeration, better biocompatibility, and enhanced biological activity. These are some of the unique physicochemical characteristics of bacterially derived nanoparticles. This comprehensive review addresses the shortcomings in the methods used for characterization, identifies the essential physicochemical and biological aspects influencing the kinetics of nanoparticle formation by bacteria, and systematically reviews the underlying molecular processes involved in such nanoparticle synthesis. Advances in biomedical research are thoroughly addressed with an emphasis on targeted drug delivery, oncological theragnostics, electrochemical biosensing, regenerative tissue engineering, and antimicrobial treatment of multidrug-resistant pathogens. Finally, the current limitations in industry, cytotoxicity concerns, regulatory hurdles, and future trends that leverage machine learning optimization and synthetic biology are critically analyzed.
